Sumitomo Mitsui DS Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Sumitomo Mitsui DS Asset Management's RPRX Position: Q3 2026 in Review
Sumitomo Mitsui DS Asset Management increased its Royalty Pharma (RPRX) stake by 4.2% in Q3 2026, buying an estimated $514K and bringing the position to 215,483 shares worth $12.6M. The position accounts for 0.09% of the portfolio, ranked #181.
Sumitomo Mitsui DS Asset Management first reported a position in RPRX in Q4 2020 and has held it in 24 quarters since. 705 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Sumitomo Mitsui DS Asset Management held 215,483 shares of Royalty Pharma worth $12.6M as of Q3 2026.
- Sumitomo Mitsui DS Asset Management bought 8,718 Royalty Pharma shares in Q3 2026, an estimated $514K.
- Royalty Pharma made up 0.09% of Sumitomo Mitsui DS Asset Management's portfolio in Q3 2026, its #181 holding.
- Sumitomo Mitsui DS Asset Management first reported a position in Royalty Pharma in Q4 2020 and has held it in 24 quarters since.
- 705 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q3 2026, filed 20 Oct 2026.